These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36289971)

  • 1. A Systematic Review of the Effect of Therapeutic Drug Monitoring on Patient Health Outcomes during Treatment with Carbapenems.
    Luxton TN; King N; Wälti C; Jeuken LJC; Sandoe JAT
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins.
    Luxton T; King N; Wälti C; Jeuken L; Sandoe J
    J Antimicrob Chemother; 2022 May; 77(6):1532-1541. PubMed ID: 35355067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis.
    Lechtig-Wasserman S; Liebisch-Rey H; Diaz-Pinilla N; Blanco J; Fuentes-Barreiro YV; Bustos RH
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33578672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
    Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of antiretrovirals for people with HIV.
    Kredo T; Van der Walt JS; Siegfried N; Cohen K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem use and therapeutic drug monitoring in clinical practice: a literature review.
    Steffens NA; Zimmermann ES; Nichelle SM; Brucker N
    J Clin Pharm Ther; 2021 Jun; 46(3):610-621. PubMed ID: 33533509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: a systematic review and meta-analysis of randomized clinical trials and observational studies.
    Gulyás E; Horváth IL; Engh MA; Bunduc S; Dembrovszky F; Fehérvári P; Bánvölgyi A; Csupor D; Hegyi P; Karvaly GB
    Sci Rep; 2024 Apr; 14(1):7793. PubMed ID: 38565898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Therapeutic Drug Monitoring and Cytochrome P450 2C19 Genotyping on Clinical Outcomes of Voriconazole: A Systematic Review.
    Lee J; Ng P; Hamandi B; Husain S; Lefebvre MJ; Battistella M
    Ann Pharmacother; 2021 Apr; 55(4):509-529. PubMed ID: 32772568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenem Antibiotics for the Empiric Treatment of Nosocomial Pneumonia: A Systematic Review and Meta-analysis.
    Howatt M; Klompas M; Kalil AC; Metersky ML; Muscedere J
    Chest; 2021 Mar; 159(3):1041-1054. PubMed ID: 33393468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-carbapenem β-lactam/β-lactamase inhibitors versus carbapenems for urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: a systematic review.
    Zhang H; Liang B; Wang J; Cai Y
    Int J Antimicrob Agents; 2021 Oct; 58(4):106410. PubMed ID: 34339776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
    Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
    J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
    Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
    Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases.
    Park MK; Lim KS; Kim TE; Han HK; Yi SJ; Shin KH; Cho JY; Shin SG; Jang IJ; Yu KS
    Ther Drug Monit; 2012 Oct; 34(5):599-603. PubMed ID: 22929406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness-Experience and Recommendations from One Year in Routine Clinical Practice.
    Scharf C; Paal M; Schroeder I; Vogeser M; Draenert R; Irlbeck M; Zoller M; Liebchen U
    Antibiotics (Basel); 2020 Mar; 9(3):. PubMed ID: 32245195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value.
    Dilworth TJ; Schulz LT; Micek ST; Kollef MH; Rose WE
    Crit Care Explor; 2022 Jul; 4(7):e0726. PubMed ID: 35815181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections.
    Agyeman AA; Bergen PJ; Rao GG; Nation RL; Landersdorfer CB
    Int J Antimicrob Agents; 2020 Jan; 55(1):105833. PubMed ID: 31730892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: A meta-analysis of randomized controlled trials.
    Eljaaly K; Enani MA; Al-Tawfiq JA
    J Infect Chemother; 2018 Nov; 24(11):915-920. PubMed ID: 30197092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.
    Sime FB; Roberts MS; Peake SL; Lipman J; Roberts JA
    Ann Intensive Care; 2012 Jul; 2(1):35. PubMed ID: 22839761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies.
    Savoldi A; Carrara E; Piddock LJV; Franceschi F; Ellis S; Chiamenti M; Bragantini D; Righi E; Tacconelli E
    BMC Infect Dis; 2021 Jun; 21(1):545. PubMed ID: 34107899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.